Unknown

Dataset Information

0

Evaluation of ERK as a therapeutic target in acute myelogenous leukemia.

ABSTRACT:

SUBMITTER: Weisberg E 

PROVIDER: S-EPMC7852028 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown <i>LYPD3</i>, a New Biomarker and Therapeutic Target for Acute Myelogenous Leukemia.
| S-EPMC8963240 | biostudies-literature
Unknown The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients.
| S-EPMC2911128 | biostudies-literature
Unknown Development of therapeutic agents for older patients with acute myelogenous leukemia.
| S-EPMC4699173 | biostudies-literature
Unknown Leveraging IFNγ/CD38 regulation to unmask and target leukemia stem cells in acute myelogenous leukemia.
| S-EPMC10002674 | biostudies-literature
Unknown Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia.
| S-EPMC4565502 | biostudies-literature
Unknown NF1 inactivation in adult acute myelogenous leukemia.
| S-EPMC2921448 | biostudies-literature
Unknown (Immuno)proteasomes as therapeutic target in acute leukemia.
| S-EPMC5721123 | biostudies-literature
Unknown The clinically relevant pharmacogenomic changes in acute myelogenous leukemia.
| S-EPMC3544213 | biostudies-literature
Unknown Immunosuppressive cells in acute myeloid leukemia: mechanisms and therapeutic target.
| S-EPMC12325080 | biostudies-literature
Unknown SRSF7 serves as a potential therapeutic target in acute myeloid leukemia.
| S-EPMC12606998 | biostudies-literature